Insulet has announced the full US market launch of its Omnipod 5 Automated Insulin Delivery System, which will now be available in retail pharmacies and through mail order for type I diabetes patients aged six years and older on a “pay-as-you-go" basis.
The Omnipod 5 is a tubeless insulin pump system that can integrate with Dexcom’s G6 continuous glucose monitor. It can also be controlled through a smartphone, though currently only some...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?